These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling. Cheng G; Wang X; Li Y; He L Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784 [TBL] [Abstract][Full Text] [Related]
63. MicroRNA‑15a‑5p induces pulmonary artery smooth muscle cell apoptosis in a pulmonary arterial hypertension model via the VEGF/p38/MMP‑2 signaling pathway. Zhang W; Li Y; Xi X; Zhu G; Wang S; Liu Y; Song M Int J Mol Med; 2020 Feb; 45(2):461-474. PubMed ID: 31894295 [TBL] [Abstract][Full Text] [Related]
64. MiR-125a-5p ameliorates monocrotaline-induced pulmonary arterial hypertension by targeting the TGF-β1 and IL-6/STAT3 signaling pathways. Cai Z; Li J; Zhuang Q; Zhang X; Yuan A; Shen L; Kang K; Qu B; Tang Y; Pu J; Gou D; Shen J Exp Mol Med; 2018 Apr; 50(4):1-11. PubMed ID: 29700287 [TBL] [Abstract][Full Text] [Related]
65. Zinc promotes cell proliferation via regulating metal-regulatory transcription factor 1 expression and transcriptional activity in pulmonary arterial hypertension. Chen A; Gao G; Lian G; Gong J; Luo L; Liu J; Chen W; Xu C; Wang H; Xie L Cell Cycle; 2023 May; 22(10):1284-1301. PubMed ID: 37128643 [TBL] [Abstract][Full Text] [Related]
66. FGF12 (Fibroblast Growth Factor 12) Inhibits Vascular Smooth Muscle Cell Remodeling in Pulmonary Arterial Hypertension. Yeo Y; Yi ES; Kim JM; Jo EK; Seo S; Kim RI; Kim KL; Sung JH; Park SG; Suh W Hypertension; 2020 Dec; 76(6):1778-1786. PubMed ID: 33100045 [TBL] [Abstract][Full Text] [Related]
67. NDUFA4L2 in smooth muscle promotes vascular remodeling in hypoxic pulmonary arterial hypertension. Liu Y; Nie X; Zhu J; Wang T; Li Y; Wang Q; Sun Z J Cell Mol Med; 2021 Jan; 25(2):1221-1237. PubMed ID: 33340241 [TBL] [Abstract][Full Text] [Related]
68. Sildenefil increases connexin 40 in smooth muscle cells through activation of BMP pathways in pulmonary arterial hypertension. Yang L; Yin N; Hu L; Fan H; Yu D; Zhang W; Wang S; Feng Y; Fan C; Cao F; Mo X Int J Clin Exp Pathol; 2014; 7(8):4674-84. PubMed ID: 25197339 [TBL] [Abstract][Full Text] [Related]
69. Inhibition of Src activation reverses pulmonary vascular remodeling in experimental pulmonary arterial hypertension via Akt/mTOR/HIF-1 signaling pathway. Liu P; Gu Y; Luo J; Ye P; Zheng Y; Yu W; Chen S Exp Cell Res; 2019 Jul; 380(1):36-46. PubMed ID: 30802452 [TBL] [Abstract][Full Text] [Related]
70. Orai1 Inhibitors as Potential Treatments for Pulmonary Arterial Hypertension. Masson B; Le Ribeuz H; Sabourin J; Laubry L; Woodhouse E; Foster R; Ruchon Y; Dutheil M; Boët A; Ghigna MR; De Montpreville VT; Mercier O; Beech DJ; Benitah JP; Bailey MA; Humbert M; Montani D; Capuano V; Antigny F Circ Res; 2022 Oct; 131(9):e102-e119. PubMed ID: 36164973 [TBL] [Abstract][Full Text] [Related]
71. NMDA-Type Glutamate Receptor Activation Promotes Vascular Remodeling and Pulmonary Arterial Hypertension. Dumas SJ; Bru-Mercier G; Courboulin A; Quatredeniers M; Rücker-Martin C; Antigny F; Nakhleh MK; Ranchoux B; Gouadon E; Vinhas MC; Vocelle M; Raymond N; Dorfmüller P; Fadel E; Perros F; Humbert M; Cohen-Kaminsky S Circulation; 2018 May; 137(22):2371-2389. PubMed ID: 29444988 [TBL] [Abstract][Full Text] [Related]
72. Pinocembrin attenuates susceptibility to atrial fibrillation in rats with pulmonary arterial hypertension. Yi Y; Tianxin Y; Zhangchi L; Cui Z; Weiguo W; Bo Y Eur J Pharmacol; 2023 Dec; 960():176169. PubMed ID: 37925134 [TBL] [Abstract][Full Text] [Related]
73. Notch3 signaling activation in smooth muscle cells promotes extrauterine growth restriction-induced pulmonary hypertension. Wang Y; Dai S; Cheng X; Prado E; Yan L; Hu J; He Q; Lv Y; Lv Y; Du L Nutr Metab Cardiovasc Dis; 2019 Jun; 29(6):639-651. PubMed ID: 30954415 [TBL] [Abstract][Full Text] [Related]
74. Thymoquinone attenuates monocrotaline-induced pulmonary artery hypertension via inhibiting pulmonary arterial remodeling in rats. Zhu N; Zhao X; Xiang Y; Ye S; Huang J; Hu W; Lv L; Zeng C Int J Cardiol; 2016 Oct; 221():587-96. PubMed ID: 27420584 [TBL] [Abstract][Full Text] [Related]
75. Phenotype and function of macrophage polarization in monocrotaline-induced pulmonary arterial hypertension rat model. Fan Y; Hao Y; Gao D; Li G; Zhang Z Physiol Res; 2021 Apr; 70(2):213-226. PubMed ID: 33676385 [TBL] [Abstract][Full Text] [Related]
76. Mural Cell SDF1 Signaling Is Associated with the Pathogenesis of Pulmonary Arterial Hypertension. Yuan K; Liu Y; Zhang Y; Nathan A; Tian W; Yu J; Sweatt AJ; Shamshou EA; Condon D; Chakraborty A; Agarwal S; Auer N; Zhang S; Wu JC; Zamanian RT; Nicolls MR; de Jesus Perez VA Am J Respir Cell Mol Biol; 2020 Jun; 62(6):747-759. PubMed ID: 32084325 [TBL] [Abstract][Full Text] [Related]
77. Activation of Calpain-2 by Mediators in Pulmonary Vascular Remodeling of Pulmonary Arterial Hypertension. Kovacs L; Han W; Rafikov R; Bagi Z; Offermanns S; Saido TC; Black SM; Su Y Am J Respir Cell Mol Biol; 2016 Mar; 54(3):384-93. PubMed ID: 26248159 [TBL] [Abstract][Full Text] [Related]
78. Tetrandrine prevents monocrotaline-induced pulmonary arterial hypertension in rats through regulation of the protein expression of inducible nitric oxide synthase and cyclic guanosine monophosphate-dependent protein kinase type 1. Wang X; Yang Y; Yang D; Tong G; Lv S; Lin X; Chen C; Dong W J Vasc Surg; 2016 Nov; 64(5):1468-1477. PubMed ID: 26527422 [TBL] [Abstract][Full Text] [Related]